Product References
PD-1/PD-L1 blockade is a potent adjuvant in treatment of Staphylococcus aureus osteomyelitis in mice.
Molecular therapy : the journal of the American Society of Gene Therapy
Li K,Chen Y,Lin Y,Zhang G,Su J,Wu X,Cheng C,Wang Y,Yu B,Zhang X
Wed Jan 04 00:00:00 UTC 2023
PD-1/PD-L1 blockade is a potent adjuvant in treatment of Staphylococcus aureus osteomyelitis in mice.
Molecular therapy : the journal of the American Society of Gene Therapy
Li K,Chen Y,Lin Y,Zhang G,Su J,Wu X,Cheng C,Wang Y,Yu B,Zhang X
Wed Jan 04 00:00:00 UTC 2023
PD-1/PD-L1 blockade is a potent adjuvant in treatment of Staphylococcus aureus osteomyelitis in mice.
Molecular therapy : the journal of the American Society of Gene Therapy
Li K,Chen Y,Lin Y,Zhang G,Su J,Wu X,Cheng C,Wang Y,Yu B,Zhang X
Wed Jan 04 00:00:00 UTC 2023
PD-1/PD-L1 blockade is a potent adjuvant in treatment of Staphylococcus aureus osteomyelitis in mice.
Molecular therapy : the journal of the American Society of Gene Therapy
Li K,Chen Y,Lin Y,Zhang G,Su J,Wu X,Cheng C,Wang Y,Yu B,Zhang X
Wed Jan 04 00:00:00 UTC 2023
PD-1/PD-L1 blockade is a potent adjuvant in treatment of Staphylococcus aureus osteomyelitis in mice.
Molecular therapy : the journal of the American Society of Gene Therapy
Li K,Chen Y,Lin Y,Zhang G,Su J,Wu X,Cheng C,Wang Y,Yu B,Zhang X
Wed Jan 04 00:00:00 UTC 2023
PD-1/PD-L1 blockade is a potent adjuvant in treatment of Staphylococcus aureus osteomyelitis in mice.
Molecular therapy : the journal of the American Society of Gene Therapy
Li K,Chen Y,Lin Y,Zhang G,Su J,Wu X,Cheng C,Wang Y,Yu B,Zhang X
Wed Jan 04 00:00:00 UTC 2023
Isothiocyanates attenuate immune checkpoint blockage therapy in gastric cancer via induction of PD-L1 expression.
The Journal of nutritional biochemistry
Zhang Q,Cao W,Yang C,Hong L,Geng S,Han H,Zhong C
Wed Feb 01 00:00:00 UTC 2023
Isothiocyanates attenuate immune checkpoint blockage therapy in gastric cancer via induction of PD-L1 expression.
The Journal of nutritional biochemistry
Zhang Q,Cao W,Yang C,Hong L,Geng S,Han H,Zhong C
Wed Feb 01 00:00:00 UTC 2023
Isothiocyanates attenuate immune checkpoint blockage therapy in gastric cancer via induction of PD-L1 expression.
The Journal of nutritional biochemistry
Zhang Q,Cao W,Yang C,Hong L,Geng S,Han H,Zhong C
Wed Feb 01 00:00:00 UTC 2023
Isothiocyanates attenuate immune checkpoint blockage therapy in gastric cancer via induction of PD-L1 expression.
The Journal of nutritional biochemistry
Zhang Q,Cao W,Yang C,Hong L,Geng S,Han H,Zhong C
Wed Feb 01 00:00:00 UTC 2023
The Role of Hedgehog Signaling in the Melanoma Tumor Bone Microenvironment.
International journal of molecular sciences
Shamsoon K,Hiraki D,Yoshida K,Takabatake K,Takebe H,Yokozeki K,Horie N,Fujita N,Nasrun NE,Okui T,Nagatsuka H,Abiko Y,Hosoya A,Saito T,Shimo T
Tue May 16 00:00:00 UTC 2023
Targeting HMGA1 contributes to immunotherapy in aggressive breast cancer while suppressing EMT.
Biochemical pharmacology
Chang X,Liu J,Yang Q,Gao Y,Ding X,Zhao J,Li Y,Liu Z,Li Z,Wu Y,Zuo D
Thu Jun 01 00:00:00 UTC 2023
Targeting HMGA1 contributes to immunotherapy in aggressive breast cancer while suppressing EMT.
Biochemical pharmacology
Chang X,Liu J,Yang Q,Gao Y,Ding X,Zhao J,Li Y,Liu Z,Li Z,Wu Y,Zuo D
Thu Jun 01 00:00:00 UTC 2023
Targeting HMGA1 contributes to immunotherapy in aggressive breast cancer while suppressing EMT.
Biochemical pharmacology
Chang X,Liu J,Yang Q,Gao Y,Ding X,Zhao J,Li Y,Liu Z,Li Z,Wu Y,Zuo D
Thu Jun 01 00:00:00 UTC 2023
Targeting HMGA1 contributes to immunotherapy in aggressive breast cancer while suppressing EMT.
Biochemical pharmacology
Chang X,Liu J,Yang Q,Gao Y,Ding X,Zhao J,Li Y,Liu Z,Li Z,Wu Y,Zuo D
Thu Jun 01 00:00:00 UTC 2023
Exosomal PD-L1 confers chemoresistance and promotes tumorigenic properties in esophageal cancer cells via upregulating STAT3/miR-21.
Gene therapy
Wang H,Qi Y,Lan Z,Liu Q,Xu J,Zhu M,Yang T,Shi R,Gao S,Liang G
Wed Feb 01 00:00:00 UTC 2023
High Infiltration of CD203c+ Mast Cells Reflects Immunosuppression and Hinders Prognostic Benefit in Stage II-III Colorectal Cancer.
Journal of inflammation research
Li J,Mo Y,Wei Q,Chen J,Xu G
Wed Mar 01 00:00:00 UTC 2023
Docosahexaenoic acid reverses PD-L1-mediated immune suppression by accelerating its ubiquitin-proteasome degradation.
The Journal of nutritional biochemistry
Zhang H,Chen H,Yin S,Fan L,Jin C,Zhao C,Hu H
Wed Feb 01 00:00:00 UTC 2023
Copper transporter gene ATP7A: A predictive biomarker for immunotherapy and targeted therapy in hepatocellular carcinoma.
International immunopharmacology
Shao K,Shen H,Chen X,Shao Z,Liu Y,Wang Y,Chen H,Wu X
Sun Jan 01 00:00:00 UTC 2023
Copper transporter gene ATP7A: A predictive biomarker for immunotherapy and targeted therapy in hepatocellular carcinoma.
International immunopharmacology
Shao K,Shen H,Chen X,Shao Z,Liu Y,Wang Y,Chen H,Wu X
Sun Jan 01 00:00:00 UTC 2023
BiTE-Secreting CAR-γδT as a Dual Targeting Strategy for the Treatment of Solid Tumors.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Huang SW,Pan CM,Lin YC,Chen MC,Chen Y,Jan CI,Wu CC,Lin FY,Wang ST,Lin CY,Lin PY,Huang WH,Chiang YT,Tsai WC,Chiu YH,Lin TH,Chiu SC,Cho DY
Thu Jun 01 00:00:00 UTC 2023
Exosomal PD‑L1 promotes the formation of an immunosuppressive microenvironment in gastric diffuse large B‑cell lymphoma.
Oncology reports
Zeng H,Wang J,Xu B,Deng H,Peng M,Deng R,Shang S,Hu Q,Li J,Lin J,Zhu H,Li Y,Zuo C
Mon May 01 00:00:00 UTC 2023
Linear Peptide-Based PET Tracers for Imaging PD-L1 in Tumors.
Molecular pharmaceutics
Zhang L,Zhang S,Wu J,Wang Y,Wu Y,Sun X,Wang X,Shen J,Xie L,Zhang Y,Zhang H,Hu K,Wang F,Wang R,Zhang MR
Mon Aug 07 00:00:00 UTC 2023
Linear Peptide-Based PET Tracers for Imaging PD-L1 in Tumors.
Molecular pharmaceutics
Zhang L,Zhang S,Wu J,Wang Y,Wu Y,Sun X,Wang X,Shen J,Xie L,Zhang Y,Zhang H,Hu K,Wang F,Wang R,Zhang MR
Mon Aug 07 00:00:00 UTC 2023
Linear Peptide-Based PET Tracers for Imaging PD-L1 in Tumors.
Molecular pharmaceutics
Zhang L,Zhang S,Wu J,Wang Y,Wu Y,Sun X,Wang X,Shen J,Xie L,Zhang Y,Zhang H,Hu K,Wang F,Wang R,Zhang MR
Mon Aug 07 00:00:00 UTC 2023
Fusobacterium nucleatum stimulates cell proliferation and promotes PD-L1 expression via IFIT1-related signal in colorectal cancer.
Neoplasia (New York, N.Y.)
Gao Y,Zou T,Xu P,Wang Y,Jiang Y,Chen YX,Chen H,Hong J,Fang JY
Sun Jan 01 00:00:00 UTC 2023
Fusobacterium nucleatum stimulates cell proliferation and promotes PD-L1 expression via IFIT1-related signal in colorectal cancer.
Neoplasia (New York, N.Y.)
Gao Y,Zou T,Xu P,Wang Y,Jiang Y,Chen YX,Chen H,Hong J,Fang JY
Sun Jan 01 00:00:00 UTC 2023
miR-4759 suppresses breast cancer through immune checkpoint blockade.
Computational and structural biotechnology journal
Lin YZ,Liu SH,Wu WR,Shen YC,Wang YL,Liao CC,Lin PL,Chang H,Liu LC,Cheng WC,Wang SC
Sat Jan 15 00:00:00 UTC 2022
miR-4759 suppresses breast cancer through immune checkpoint blockade.
Computational and structural biotechnology journal
Lin YZ,Liu SH,Wu WR,Shen YC,Wang YL,Liao CC,Lin PL,Chang H,Liu LC,Cheng WC,Wang SC
Sat Jan 15 00:00:00 UTC 2022
miR-4759 suppresses breast cancer through immune checkpoint blockade.
Computational and structural biotechnology journal
Lin YZ,Liu SH,Wu WR,Shen YC,Wang YL,Liao CC,Lin PL,Chang H,Liu LC,Cheng WC,Wang SC
Sat Jan 15 00:00:00 UTC 2022
miR-4759 suppresses breast cancer through immune checkpoint blockade.
Computational and structural biotechnology journal
Lin YZ,Liu SH,Wu WR,Shen YC,Wang YL,Liao CC,Lin PL,Chang H,Liu LC,Cheng WC,Wang SC
Sat Jan 15 00:00:00 UTC 2022
Syngeneically transplanted insulin producing cells differentiated from adipose derived stem cells undergo delayed damage by autoimmune responses in NOD mice.
Scientific reports
Tokuda K,Ikemoto T,Yamashita S,Miyazaki K,Okikawa S,Yamada S,Saito Y,Morine Y,Shimada M
Thu Apr 07 00:00:00 UTC 2022
Syngeneically transplanted insulin producing cells differentiated from adipose derived stem cells undergo delayed damage by autoimmune responses in NOD mice.
Scientific reports
Tokuda K,Ikemoto T,Yamashita S,Miyazaki K,Okikawa S,Yamada S,Saito Y,Morine Y,Shimada M
Thu Apr 07 00:00:00 UTC 2022
Piperlongumine, a piper alkaloid, enhances the efficacy of doxorubicin in breast cancer: involvement of glucose import, ROS, NF-κB and lncRNAs.
Apoptosis : an international journal on programmed cell death
Awasthee N,Shekher A,Rai V,Verma SS,Mishra S,Dhasmana A,Gupta SC
Fri Apr 01 00:00:00 UTC 2022
Ag nanoparticles enhance immune checkpoint blockade efficacy by promoting of immune surveillance in melanoma.
Journal of colloid and interface science
Kuang X,Wang Z,Luo Z,He Z,Liang L,Gao Q,Li Y,Xia K,Xie Z,Chang R,Wang Y,Liu Y,Zhao S,Su J,Wang Y,Situ W,Chen M,Zhao Y,Chen X,Xie H,Liu H
Wed Jun 15 00:00:00 UTC 2022
Ag nanoparticles enhance immune checkpoint blockade efficacy by promoting of immune surveillance in melanoma.
Journal of colloid and interface science
Kuang X,Wang Z,Luo Z,He Z,Liang L,Gao Q,Li Y,Xia K,Xie Z,Chang R,Wang Y,Liu Y,Zhao S,Su J,Wang Y,Situ W,Chen M,Zhao Y,Chen X,Xie H,Liu H
Wed Jun 15 00:00:00 UTC 2022
Ag nanoparticles enhance immune checkpoint blockade efficacy by promoting of immune surveillance in melanoma.
Journal of colloid and interface science
Kuang X,Wang Z,Luo Z,He Z,Liang L,Gao Q,Li Y,Xia K,Xie Z,Chang R,Wang Y,Liu Y,Zhao S,Su J,Wang Y,Situ W,Chen M,Zhao Y,Chen X,Xie H,Liu H
Wed Jun 15 00:00:00 UTC 2022
Ag nanoparticles enhance immune checkpoint blockade efficacy by promoting of immune surveillance in melanoma.
Journal of colloid and interface science
Kuang X,Wang Z,Luo Z,He Z,Liang L,Gao Q,Li Y,Xia K,Xie Z,Chang R,Wang Y,Liu Y,Zhao S,Su J,Wang Y,Situ W,Chen M,Zhao Y,Chen X,Xie H,Liu H
Wed Jun 15 00:00:00 UTC 2022
High efficacy of PD-1 inhibitor after initial failure of PD-L1 inhibitor in Relapsed/Refractory classical Hodgkin Lymphoma.
BMC cancer
Chen X,Kong H,Luo L,Han S,Lei T,Yu H,Guo N,Li C,Peng S,Dong X,Yang H,Wu M
Mon Jan 03 00:00:00 UTC 2022
Exosome-transmitted S100A4 induces immunosuppression and non-small cell lung cancer development by activating STAT3.
Clinical and experimental immunology
Wu X,Zhang H,Jiang G,Peng M,Li C,Lu J,Jiang S,Yang X,Jiang Y
Sat Dec 31 00:00:00 UTC 2022
Exosome-transmitted S100A4 induces immunosuppression and non-small cell lung cancer development by activating STAT3.
Clinical and experimental immunology
Wu X,Zhang H,Jiang G,Peng M,Li C,Lu J,Jiang S,Yang X,Jiang Y
Sat Dec 31 00:00:00 UTC 2022
Exosome-transmitted S100A4 induces immunosuppression and non-small cell lung cancer development by activating STAT3.
Clinical and experimental immunology
Wu X,Zhang H,Jiang G,Peng M,Li C,Lu J,Jiang S,Yang X,Jiang Y
Sat Dec 31 00:00:00 UTC 2022
Exosome-transmitted S100A4 induces immunosuppression and non-small cell lung cancer development by activating STAT3.
Clinical and experimental immunology
Wu X,Zhang H,Jiang G,Peng M,Li C,Lu J,Jiang S,Yang X,Jiang Y
Sat Dec 31 00:00:00 UTC 2022
Exosome-transmitted S100A4 induces immunosuppression and non-small cell lung cancer development by activating STAT3.
Clinical and experimental immunology
Wu X,Zhang H,Jiang G,Peng M,Li C,Lu J,Jiang S,Yang X,Jiang Y
Sat Dec 31 00:00:00 UTC 2022
Exosome-transmitted S100A4 induces immunosuppression and non-small cell lung cancer development by activating STAT3.
Clinical and experimental immunology
Wu X,Zhang H,Jiang G,Peng M,Li C,Lu J,Jiang S,Yang X,Jiang Y
Sat Dec 31 00:00:00 UTC 2022
PTX3 mediates the infiltration, migration, and inflammation-resolving-polarization of macrophages in glioblastoma.
CNS neuroscience & therapeutics
Zhang H,Wang Y,Zhao Y,Liu T,Wang Z,Zhang N,Dai Z,Wu W,Cao H,Feng S,Zhang L,Cheng Q,Liu Z
Tue Nov 01 00:00:00 UTC 2022
A single-beam of light priming the immune responses and boosting cancer photoimmunotherapy.
Journal of controlled release : official journal of the Controlled Release Society
Sun Y,Han R,Wang J,Qin Y,Ren Z,Feng X,Liu Q,Wang X
Sat Oct 01 00:00:00 UTC 2022
A single-beam of light priming the immune responses and boosting cancer photoimmunotherapy.
Journal of controlled release : official journal of the Controlled Release Society
Sun Y,Han R,Wang J,Qin Y,Ren Z,Feng X,Liu Q,Wang X
Sat Oct 01 00:00:00 UTC 2022
Small extracellular vesicles derived from PD-L1-modified mesenchymal stem cell promote Tregs differentiation and prolong allograft survival.
Cell and tissue research
Ou Q,Dou X,Tang J,Wu P,Pan D
Thu Sep 01 00:00:00 UTC 2022
Blocking PD-L1-PD-1 improves senescence surveillance and ageing phenotypes.
Nature
Wang TW,Johmura Y,Suzuki N,Omori S,Migita T,Yamaguchi K,Hatakeyama S,Yamazaki S,Shimizu E,Imoto S,Furukawa Y,Yoshimura A,Nakanishi M
Tue Nov 01 00:00:00 UTC 2022
Blocking PD-L1-PD-1 improves senescence surveillance and ageing phenotypes.
Nature
Wang TW,Johmura Y,Suzuki N,Omori S,Migita T,Yamaguchi K,Hatakeyama S,Yamazaki S,Shimizu E,Imoto S,Furukawa Y,Yoshimura A,Nakanishi M
Tue Nov 01 00:00:00 UTC 2022
Blocking PD-L1-PD-1 improves senescence surveillance and ageing phenotypes.
Nature
Wang TW,Johmura Y,Suzuki N,Omori S,Migita T,Yamaguchi K,Hatakeyama S,Yamazaki S,Shimizu E,Imoto S,Furukawa Y,Yoshimura A,Nakanishi M
Tue Nov 01 00:00:00 UTC 2022
Traditional Chinese medicine CFF-1 exerts a potent anti-tumor immunity to hinder tumor growth and metastasis in prostate cancer through EGFR/JAK1/STAT3 pathway to inhibit PD-1/PD-L1 checkpoint signaling.
Phytomedicine : international journal of phytotherapy and phytopharmacology
Zhang Y,Wei Y,Jiang S,Dang Y,Yang Y,Zuo W,Zhu Q,Liu P,Gao Y,Lu S
Sun May 01 00:00:00 UTC 2022
Bifidobacterium infantis Promotes Foxp3 Expression in Colon Cells via PD-L1-Mediated Inhibition of the PI3K-Akt-mTOR Signaling Pathway.
Frontiers in immunology
Zhou L,Xie Y,Li Y
Fri Jul 22 00:00:00 UTC 2022
Bifidobacterium infantis Promotes Foxp3 Expression in Colon Cells via PD-L1-Mediated Inhibition of the PI3K-Akt-mTOR Signaling Pathway.
Frontiers in immunology
Zhou L,Xie Y,Li Y
Fri Jul 22 00:00:00 UTC 2022
Programmed death-ligand 1 signaling and expression are reversible by lycopene via PI3K/AKT and Raf/MEK/ERK pathways in tongue squamous cell carcinoma.
Genes & nutrition
Peng M,Fan S,Li J,Zhou X,Liao Q,Tang F,Liu W
Mon Feb 14 00:00:00 UTC 2022
Antimelanoma Effects of Concomitant Inhibition of SIRT1 and SIRT3 in BrafV600E/PtenNULL Mice.
The Journal of investigative dermatology
Chhabra G,Singh CK,Guzmán-Pérez G,Ndiaye MA,Iczkowski KA,Ahmad N
Fri Apr 01 00:00:00 UTC 2022
Ubiquitin ligase RNF125 targets PD-L1 for ubiquitination and degradation.
Frontiers in oncology
Wei M,Mo Y,Liu J,Zhai J,Li H,Xu Y,Peng Y,Tang Z,Wei T,Yang X,Huang L,Shao X,Li J,Zhou L,Zhong H,Wei C,Xie Q,Min M,Wu F
Tue Aug 16 00:00:00 UTC 2022
Ubiquitin ligase RNF125 targets PD-L1 for ubiquitination and degradation.
Frontiers in oncology
Wei M,Mo Y,Liu J,Zhai J,Li H,Xu Y,Peng Y,Tang Z,Wei T,Yang X,Huang L,Shao X,Li J,Zhou L,Zhong H,Wei C,Xie Q,Min M,Wu F
Tue Aug 16 00:00:00 UTC 2022
Ubiquitin ligase RNF125 targets PD-L1 for ubiquitination and degradation.
Frontiers in oncology
Wei M,Mo Y,Liu J,Zhai J,Li H,Xu Y,Peng Y,Tang Z,Wei T,Yang X,Huang L,Shao X,Li J,Zhou L,Zhong H,Wei C,Xie Q,Min M,Wu F
Tue Aug 16 00:00:00 UTC 2022
Liver kinase B1 in exosomes inhibits immune checkpoint programmed death ligand 1 and metastatic progression of intrahepatic cholangiocarcinoma.
Oncology reports
Liu Z,Zhou K,Zeng J,Zhou X,Li H,Peng K,Liu X,Li F,Jiang B,Zhao M,Ma T
Thu Sep 01 00:00:00 UTC 2022
DDR1 functions as an immune negative factor in colorectal cancer by regulating tumor-infiltrating T cells through IL-18.
Cancer science
Duan X,Xu X,Zhang Y,Gao Y,Zhou J,Li J
Tue Nov 01 00:00:00 UTC 2022
Biomimetic cell membrane-coated glucose/oxygen-exhausting nanoreactor for remodeling tumor microenvironment in targeted hypoxic tumor therapy.
Biomaterials
Guo H,Zhang W,Wang L,Shao Z,Huang X
Tue Nov 01 00:00:00 UTC 2022
Modulating Lysine Crotonylation in Cardiomyocytes Improves Myocardial Outcomes.
Circulation research
Cai W,Xu D,Zeng C,Liao F,Li R,Lin Y,Zhao Y,Dong W,Wang Q,Yang H,Wen D,Gu J,Shentu W,Yu H,Zhang X,Wei J,Duan J
Fri Aug 19 00:00:00 UTC 2022
PD-1 inhibitor causes pathological injury to multiple organs in a Lewis lung cancer mouse model.
International immunopharmacology
Chen Y,Liu Y,Xiong X,Zeng Z,Luo D,Liu A
Fri Apr 01 00:00:00 UTC 2022
In situ injectable hydrogel-loaded drugs induce anti-tumor immune responses in melanoma immunochemotherapy.
Materials today. Bio
Li J,Luo G,Zhang C,Long S,Guo L,Yang G,Wang F,Zhang L,Shi L,Fu Y,Zhang Y
Tue Mar 01 00:00:00 UTC 2022
The programmed site-specific delivery of LY3200882 and PD-L1 siRNA boosts immunotherapy for triple-negative breast cancer by remodeling tumor microenvironment.
Biomaterials
Zhang P,Qin C,Liu N,Zhou X,Chu X,Lv F,Gu Y,Yin L,Liu J,Zhou J,Huo M
Sun May 01 00:00:00 UTC 2022
The programmed site-specific delivery of LY3200882 and PD-L1 siRNA boosts immunotherapy for triple-negative breast cancer by remodeling tumor microenvironment.
Biomaterials
Zhang P,Qin C,Liu N,Zhou X,Chu X,Lv F,Gu Y,Yin L,Liu J,Zhou J,Huo M
Sun May 01 00:00:00 UTC 2022
Angiotensin-converting enzyme 2 identifies immuno-hot tumors suggesting angiotensin-(1-7) as a sensitizer for chemotherapy and immunotherapy in breast cancer.
Biological procedures online
Mei J,Cai Y,Xu R,Yu X,Han X,Weng M,Chen L,Ma T,Gao T,Gao F,Xia T,Zhu Y,Zhang Y
Tue Oct 25 00:00:00 UTC 2022
Angiotensin-converting enzyme 2 identifies immuno-hot tumors suggesting angiotensin-(1-7) as a sensitizer for chemotherapy and immunotherapy in breast cancer.
Biological procedures online
Mei J,Cai Y,Xu R,Yu X,Han X,Weng M,Chen L,Ma T,Gao T,Gao F,Xia T,Zhu Y,Zhang Y
Tue Oct 25 00:00:00 UTC 2022
Anti-PD-L1 F(ab) Conjugated PEG-PLGA Nanoparticle Enhances Immune Checkpoint Therapy.
Nanotheranostics
Lee CK,Atibalentja DF,Yao LE,Park J,Kuruvilla S,Felsher DW
Wed Mar 16 00:00:00 UTC 2022
eEF2K promotes PD-L1 stabilization through inactivating GSK3β in melanoma.
Journal for immunotherapy of cancer
Chen X,Wang K,Jiang S,Sun H,Che X,Zhang M,He J,Wen Y,Liao M,Li X,Zhou X,Song J,Ren X,Yi W,Yang J,Chen X,Yin M,Cheng Y
Tue Mar 01 00:00:00 UTC 2022
eEF2K promotes PD-L1 stabilization through inactivating GSK3β in melanoma.
Journal for immunotherapy of cancer
Chen X,Wang K,Jiang S,Sun H,Che X,Zhang M,He J,Wen Y,Liao M,Li X,Zhou X,Song J,Ren X,Yi W,Yang J,Chen X,Yin M,Cheng Y
Tue Mar 01 00:00:00 UTC 2022
Bifidobacterium infantis regulates the programmed cell death 1 pathway and immune response in mice with inflammatory bowel disease.
World journal of gastroenterology
Zhou LY,Xie Y,Li Y
Thu Jul 14 00:00:00 UTC 2022
Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint blockade.
Diabetologia
Kawada-Horitani E,Kita S,Okita T,Nakamura Y,Nishida H,Honma Y,Fukuda S,Tsugawa-Shimizu Y,Kozawa J,Sakaue T,Kawachi Y,Fujishima Y,Nishizawa H,Azuma M,Maeda N,Shimomura I
Fri Jul 01 00:00:00 UTC 2022
STING mediates nuclear PD-L1 targeting-induced senescence in cancer cells.
Cell death & disease
Lee JJ,Kim SY,Kim SH,Choi S,Lee B,Shin JS
Thu Sep 15 00:00:00 UTC 2022
STING mediates nuclear PD-L1 targeting-induced senescence in cancer cells.
Cell death & disease
Lee JJ,Kim SY,Kim SH,Choi S,Lee B,Shin JS
Thu Sep 15 00:00:00 UTC 2022
STING mediates nuclear PD-L1 targeting-induced senescence in cancer cells.
Cell death & disease
Lee JJ,Kim SY,Kim SH,Choi S,Lee B,Shin JS
Thu Sep 15 00:00:00 UTC 2022
STING mediates nuclear PD-L1 targeting-induced senescence in cancer cells.
Cell death & disease
Lee JJ,Kim SY,Kim SH,Choi S,Lee B,Shin JS
Thu Sep 15 00:00:00 UTC 2022
Whole-body PET tracking of a d-dodecapeptide and its radiotheranostic potential for PD-L1 overexpressing tumors.
Acta pharmaceutica Sinica. B
Hu K,Wu W,Xie L,Geng H,Zhang Y,Hanyu M,Zhang L,Liu Y,Nagatsu K,Suzuki H,Guo J,Wu Y,Li Z,Wang F,Zhang M
Tue Mar 01 00:00:00 UTC 2022
Whole-body PET tracking of a d-dodecapeptide and its radiotheranostic potential for PD-L1 overexpressing tumors.
Acta pharmaceutica Sinica. B
Hu K,Wu W,Xie L,Geng H,Zhang Y,Hanyu M,Zhang L,Liu Y,Nagatsu K,Suzuki H,Guo J,Wu Y,Li Z,Wang F,Zhang M
Tue Mar 01 00:00:00 UTC 2022
Whole-body PET tracking of a d-dodecapeptide and its radiotheranostic potential for PD-L1 overexpressing tumors.
Acta pharmaceutica Sinica. B
Hu K,Wu W,Xie L,Geng H,Zhang Y,Hanyu M,Zhang L,Liu Y,Nagatsu K,Suzuki H,Guo J,Wu Y,Li Z,Wang F,Zhang M
Tue Mar 01 00:00:00 UTC 2022
Whole-body PET tracking of a d-dodecapeptide and its radiotheranostic potential for PD-L1 overexpressing tumors.
Acta pharmaceutica Sinica. B
Hu K,Wu W,Xie L,Geng H,Zhang Y,Hanyu M,Zhang L,Liu Y,Nagatsu K,Suzuki H,Guo J,Wu Y,Li Z,Wang F,Zhang M
Tue Mar 01 00:00:00 UTC 2022
Nintedanib enhances the efficacy of PD-L1 blockade by upregulating MHC-I and PD-L1 expression in tumor cells.
Theranostics
Tu J,Xu H,Ma L,Li C,Qin W,Chen X,Yi M,Sun L,Liu B,Yuan X
Thu Mar 10 00:00:00 UTC 2022
MCT4/Lactate Promotes PD-L1 Glycosylation in Triple-Negative Breast Cancer Cells.
Journal of oncology
Duan X,Xie Y,Yu J,Hu X,Liu Z,Li N,Qin J,Lan L,Yuan M,Pan Z,Wang Y
Fri Oct 07 00:00:00 UTC 2022
Targeted Nanobubbles of PD-L1 mAb Combined with Doxorubicin as a Synergistic Tumor Repressor in Hepatocarcinoma.
International journal of nanomedicine
Chen Y,Luo X,Liu Y,Zou Y,Yang S,Liu C,Zhao Y
Fri Sep 16 00:00:00 UTC 2022
PD-1/PD-L1 enhanced cisplatin resistance in gastric cancer through PI3K/AKT mediated P-gp expression.
International immunopharmacology
Wu L,Cai S,Deng Y,Zhang Z,Zhou X,Su Y,Xu D
Sat May 01 00:00:00 UTC 2021
PD-1/PD-L1 enhanced cisplatin resistance in gastric cancer through PI3K/AKT mediated P-gp expression.
International immunopharmacology
Wu L,Cai S,Deng Y,Zhang Z,Zhou X,Su Y,Xu D
Sat May 01 00:00:00 UTC 2021
Relationship between immune checkpoint proteins, tumour microenvironment characteristics, and prognosis in primary operable colorectal cancer.
The journal of pathology. Clinical research
Al-Badran SS,Grant L,Campo MV,Inthagard J,Pennel K,Quinn J,Konanahalli P,Hayman L,Horgan PG,McMillan DC,Roxburgh CS,Roseweir A,Park JH,Edwards J
Mon Mar 01 00:00:00 UTC 2021
Arsenic sulfide reverses cisplatin resistance in non-small cell lung cancer in vitro and in vivo through targeting PD-L1.
Thoracic cancer
Tian W,Sun Y,Cheng Y,Ma X,Du W,Shi W,Guo Q
Fri Oct 01 00:00:00 UTC 2021
Helicobacter pylori infection disturbs the tumor immune microenvironment and is associated with a discrepant prognosis in gastric de novo diffuse large B-cell lymphoma.
Journal for immunotherapy of cancer
Deng Y,Su W,Zhu J,Ji H,Zhou X,Geng J,Zhu J,Zhang Q
Fri Oct 01 00:00:00 UTC 2021
TRAPPC4 regulates the intracellular trafficking of PD-L1 and antitumor immunity.
Nature communications
Ren Y,Qian Y,Ai L,Xie Y,Gao Y,Zhuang Z,Chen J,Chen YX,Fang JY
Mon Sep 13 00:00:00 UTC 2021
TRAPPC4 regulates the intracellular trafficking of PD-L1 and antitumor immunity.
Nature communications
Ren Y,Qian Y,Ai L,Xie Y,Gao Y,Zhuang Z,Chen J,Chen YX,Fang JY
Mon Sep 13 00:00:00 UTC 2021
TRAPPC4 regulates the intracellular trafficking of PD-L1 and antitumor immunity.
Nature communications
Ren Y,Qian Y,Ai L,Xie Y,Gao Y,Zhuang Z,Chen J,Chen YX,Fang JY
Mon Sep 13 00:00:00 UTC 2021
TRAPPC4 regulates the intracellular trafficking of PD-L1 and antitumor immunity.
Nature communications
Ren Y,Qian Y,Ai L,Xie Y,Gao Y,Zhuang Z,Chen J,Chen YX,Fang JY
Mon Sep 13 00:00:00 UTC 2021
CXCL6 fuels the growth and metastases of esophageal squamous cell carcinoma cells both in vitro and in vivo through upregulation of PD-L1 via activation of STAT3 pathway.
Journal of cellular physiology
Zheng S,Shen T,Liu Q,Liu T,Tuerxun A,Zhang Q,Yang L,Han X,Lu X
Thu Jul 01 00:00:00 UTC 2021
CXCL6 fuels the growth and metastases of esophageal squamous cell carcinoma cells both in vitro and in vivo through upregulation of PD-L1 via activation of STAT3 pathway.
Journal of cellular physiology
Zheng S,Shen T,Liu Q,Liu T,Tuerxun A,Zhang Q,Yang L,Han X,Lu X
Thu Jul 01 00:00:00 UTC 2021
KPNB1-mediated nuclear translocation of PD-L1 promotes non-small cell lung cancer cell proliferation via the Gas6/MerTK signaling pathway.
Cell death and differentiation
Du W,Zhu J,Zeng Y,Liu T,Zhang Y,Cai T,Fu Y,Zhang W,Zhang R,Liu Z,Huang JA
Thu Apr 01 00:00:00 UTC 2021
KPNB1-mediated nuclear translocation of PD-L1 promotes non-small cell lung cancer cell proliferation via the Gas6/MerTK signaling pathway.
Cell death and differentiation
Du W,Zhu J,Zeng Y,Liu T,Zhang Y,Cai T,Fu Y,Zhang W,Zhang R,Liu Z,Huang JA
Thu Apr 01 00:00:00 UTC 2021
THADA drives Golgi residency and upregulation of PD-L1 in cancer cells and provides promising target for immunotherapy.
Journal for immunotherapy of cancer
Li C,Chi H,Deng S,Wang H,Yao H,Wang Y,Chen D,Guo X,Fang JY,He F,Xu J
Sun Aug 01 00:00:00 UTC 2021
THADA drives Golgi residency and upregulation of PD-L1 in cancer cells and provides promising target for immunotherapy.
Journal for immunotherapy of cancer
Li C,Chi H,Deng S,Wang H,Yao H,Wang Y,Chen D,Guo X,Fang JY,He F,Xu J
Sun Aug 01 00:00:00 UTC 2021
THADA drives Golgi residency and upregulation of PD-L1 in cancer cells and provides promising target for immunotherapy.
Journal for immunotherapy of cancer
Li C,Chi H,Deng S,Wang H,Yao H,Wang Y,Chen D,Guo X,Fang JY,He F,Xu J
Sun Aug 01 00:00:00 UTC 2021
THADA drives Golgi residency and upregulation of PD-L1 in cancer cells and provides promising target for immunotherapy.
Journal for immunotherapy of cancer
Li C,Chi H,Deng S,Wang H,Yao H,Wang Y,Chen D,Guo X,Fang JY,He F,Xu J
Sun Aug 01 00:00:00 UTC 2021
THADA drives Golgi residency and upregulation of PD-L1 in cancer cells and provides promising target for immunotherapy.
Journal for immunotherapy of cancer
Li C,Chi H,Deng S,Wang H,Yao H,Wang Y,Chen D,Guo X,Fang JY,He F,Xu J
Sun Aug 01 00:00:00 UTC 2021
THADA drives Golgi residency and upregulation of PD-L1 in cancer cells and provides promising target for immunotherapy.
Journal for immunotherapy of cancer
Li C,Chi H,Deng S,Wang H,Yao H,Wang Y,Chen D,Guo X,Fang JY,He F,Xu J
Sun Aug 01 00:00:00 UTC 2021
Synergy of nanodiamond-doxorubicin conjugates and PD-L1 blockade effectively turns tumor-associated macrophages against tumor cells.
Journal of nanobiotechnology
Xu HZ,Li TF,Wang C,Ma Y,Liu Y,Zheng MY,Liu ZJ,Chen JB,Li K,Sun SK,Komatsu N,Xu YH,Zhao L,Chen X
Mon Sep 06 00:00:00 UTC 2021
Synergy of nanodiamond-doxorubicin conjugates and PD-L1 blockade effectively turns tumor-associated macrophages against tumor cells.
Journal of nanobiotechnology
Xu HZ,Li TF,Wang C,Ma Y,Liu Y,Zheng MY,Liu ZJ,Chen JB,Li K,Sun SK,Komatsu N,Xu YH,Zhao L,Chen X
Mon Sep 06 00:00:00 UTC 2021
Synergy of nanodiamond-doxorubicin conjugates and PD-L1 blockade effectively turns tumor-associated macrophages against tumor cells.
Journal of nanobiotechnology
Xu HZ,Li TF,Wang C,Ma Y,Liu Y,Zheng MY,Liu ZJ,Chen JB,Li K,Sun SK,Komatsu N,Xu YH,Zhao L,Chen X
Mon Sep 06 00:00:00 UTC 2021
Synergy of nanodiamond-doxorubicin conjugates and PD-L1 blockade effectively turns tumor-associated macrophages against tumor cells.
Journal of nanobiotechnology
Xu HZ,Li TF,Wang C,Ma Y,Liu Y,Zheng MY,Liu ZJ,Chen JB,Li K,Sun SK,Komatsu N,Xu YH,Zhao L,Chen X
Mon Sep 06 00:00:00 UTC 2021
Synergy of nanodiamond-doxorubicin conjugates and PD-L1 blockade effectively turns tumor-associated macrophages against tumor cells.
Journal of nanobiotechnology
Xu HZ,Li TF,Wang C,Ma Y,Liu Y,Zheng MY,Liu ZJ,Chen JB,Li K,Sun SK,Komatsu N,Xu YH,Zhao L,Chen X
Mon Sep 06 00:00:00 UTC 2021
Synergy of nanodiamond-doxorubicin conjugates and PD-L1 blockade effectively turns tumor-associated macrophages against tumor cells.
Journal of nanobiotechnology
Xu HZ,Li TF,Wang C,Ma Y,Liu Y,Zheng MY,Liu ZJ,Chen JB,Li K,Sun SK,Komatsu N,Xu YH,Zhao L,Chen X
Mon Sep 06 00:00:00 UTC 2021
Enhanced response to PD-L1 silencing by modulation of TME via balancing glucose metabolism and robust co-delivery of siRNA/Resveratrol with dual-responsive polyplexes.
Biomaterials
Jia L,Gao Y,Zhou T,Zhao XL,Hu HY,Chen DW,Qiao MX
Thu Apr 01 00:00:00 UTC 2021
Inhibition of NF-κB is required for oleanolic acid to downregulate PD-L1 by promoting DNA demethylation in gastric cancer cells.
Journal of biochemical and molecular toxicology
Lu X,Li Y,Yang W,Tao M,Dai Y,Xu J,Xu Q
Fri Jan 01 00:00:00 UTC 2021
Repurposing screen identifies Amlodipine as an inducer of PD-L1 degradation and antitumor immunity.
Oncogene
Li C,Yao H,Wang H,Fang JY,Xu J
Mon Feb 01 00:00:00 UTC 2021
Anticancer nanocage platforms for combined immunotherapy designed to harness immune checkpoints and deliver anticancer drugs.
Biomaterials
Jeon IS,Yoo JD,Gurung S,Kim M,Lee C,Park EJ,Park RW,Lee B,Kim S
Mon Mar 01 00:00:00 UTC 2021
Epithelial Mutant p53 Promotes Resistance to Anti-PD-1-Mediated Oral Cancer Immunoprevention in Carcinogen-Induced Mouse Models.
Cancers
Wang J,Hu Y,Escamilla-Rivera V,Gonzalez CL,Tang L,Wang B,El-Naggar AK,Myers JN,Caulin C
Tue Mar 23 00:00:00 UTC 2021
Activity of the growth hormone-releasing hormone antagonist MIA602 and its underlying mechanisms of action in sarcoidosis-like granuloma.
Clinical & translational immunology
Zhang C,Tian R,Dreifus EM,Hashemi Shahraki A,Holt G,Cai R,Griswold A,Bejarano P,Jackson R,V Schally A,Mirsaeidi M
Sun May 05 00:00:00 UTC 2024
PD-L1 expression and patient outcomes in gastrointestinal neuroendocrine neoplasm: a meta-analysis.
Translational cancer research
Lee W,Kim MJ,Choi Y,Kim H
Sat May 01 00:00:00 UTC 2021
PDIA6 promotes pancreatic cancer progression and immune escape through CSN5-mediated deubiquitination of β-catenin and PD-L1.
Neoplasia (New York, N.Y.)
Ma Y,Xia P,Wang Z,Xu J,Zhang L,Jiang Y
Wed Sep 01 00:00:00 UTC 2021
PDIA6 promotes pancreatic cancer progression and immune escape through CSN5-mediated deubiquitination of β-catenin and PD-L1.
Neoplasia (New York, N.Y.)
Ma Y,Xia P,Wang Z,Xu J,Zhang L,Jiang Y
Wed Sep 01 00:00:00 UTC 2021
Nanoparticle-Mediated Delivery of 2-Deoxy-D-Glucose Induces Antitumor Immunity and Cytotoxicity in Liver Tumors in Mice.
Cellular and molecular gastroenterology and hepatology
Sasaki K,Nishina S,Yamauchi A,Fukuda K,Hara Y,Yamamura M,Egashira K,Hino K
Mon Dec 20 00:00:00 UTC 2021
Mild hyperthermia promotes immune checkpoint blockade-based immunotherapy against metastatic pancreatic cancer using size-adjustable nanoparticles.
Acta biomaterialia
Yu Q,Tang X,Zhao W,Qiu Y,He J,Wan D,Li J,Wang X,He X,Liu Y,Li M,Zhang Z,He Q
Fri Oct 01 00:00:00 UTC 2021
Helicobacter urease suppresses cytotoxic CD8+ T-cell responses through activating Myh9-dependent induction of PD-L1.
International immunology
Wu J,Zhu X,Guo X,Yang Z,Cai Q,Gu D,Luo W,Yuan C,Xiang Y
Mon Aug 23 00:00:00 UTC 2021
Generation of triacyl lipopeptide-modified glycoproteins by metabolic glycoengineering as the neoantigen to boost anti-tumor immune response.
Theranostics
Zhao Y,Li S,Lv J,Liu Y,Chen Y,Liu Y,Chen X,Li J,Qin X,Wang X,Shi J,Shi Y,Xiang R
Wed Jul 28 00:00:00 UTC 2021
Aldehyde Dehydrogenase 2 Mediates Alcohol-Induced Colorectal Cancer Immune Escape through Stabilizing PD-L1 Expression.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Zhang H,Xia Y,Wang F,Luo M,Yang K,Liang S,An S,Wu S,Yang C,Chen D,Xu M,Cai M,To KKW,Fu L
Sat May 01 00:00:00 UTC 2021
WSX1 act as a tumor suppressor in hepatocellular carcinoma by downregulating neoplastic PD-L1 expression.
Nature communications
Wu M,Xia X,Hu J,Fowlkes NW,Li S
Wed Jun 09 00:00:00 UTC 2021
ZG16 regulates PD-L1 expression and promotes local immunity in colon cancer.
Translational oncology
Meng H,Ding Y,Liu E,Li W,Wang L
Mon Feb 01 00:00:00 UTC 2021
Oxymatrine reduces expression of programmed death-ligand 1 by promoting DNA demethylation in colorectal cancer cells.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Hua S,Gu M,Wang Y,Ban D,Ji H
Thu Apr 01 00:00:00 UTC 2021
The innate immune effector ISG12a promotes cancer immunity by suppressing the canonical Wnt/β-catenin signaling pathway.
Cellular & molecular immunology
Deng R,Zuo C,Li Y,Xue B,Xun Z,Guo Y,Wang X,Xu Y,Tian R,Chen S,Liu Q,Chen J,Wang J,Huang X,Li H,Guo M,Wang X,Yang M,Wu Z,Wang J,Ma J,Hu J,Li G,Tang S,Tu Z,Ji H,Zhu H
Sun Nov 01 00:00:00 UTC 2020
The innate immune effector ISG12a promotes cancer immunity by suppressing the canonical Wnt/β-catenin signaling pathway.
Cellular & molecular immunology
Deng R,Zuo C,Li Y,Xue B,Xun Z,Guo Y,Wang X,Xu Y,Tian R,Chen S,Liu Q,Chen J,Wang J,Huang X,Li H,Guo M,Wang X,Yang M,Wu Z,Wang J,Ma J,Hu J,Li G,Tang S,Tu Z,Ji H,Zhu H
Sun Nov 01 00:00:00 UTC 2020
Differentiation of cancer cells upregulates HLA‑G and PD‑L1.
Oncology reports
Ullah M,Meziani S,Shah S,Kaci R,Pimpie C,Pocard M,Mirshahi M
Mon Jun 01 00:00:00 UTC 2020
MiR-34a suppresses the proliferation and invasion of gastric cancer by modulating PDL1 in the immune microenvironment.
Molecular and cellular probes
Yong H,Fu J,Gao G,Shi H,Zheng D,Zhou X
Thu Oct 01 00:00:00 UTC 2020
Apatinib enhanced anti-PD-1 therapy for colon cancer in mice via promoting PD-L1 expression.
International immunopharmacology
Cai X,Wei B,Li L,Chen X,Liu W,Cui J,Lin Y,Sun Y,Xu Q,Guo W,Gu Y
Sun Nov 01 00:00:00 UTC 2020
The differences of immunologic and TP53 mutant phenotypes between synchronous and metachronous head and neck cancer and esophageal cancer.
Oral oncology
Chen TC,Wu CT,Wang CP,Lou PJ,Ko JY,Chang YL
Tue Dec 01 00:00:00 UTC 2020
LKB1 inhibits intrahepatic cholangiocarcinoma by repressing the transcriptional activity of the immune checkpoint PD-L1.
Life sciences
Liu Z,Li S,Zeng J,Zhou X,Li H,Liu X,Li F,Jiang B,Zhao M,Ma T
Tue Sep 15 00:00:00 UTC 2020
LKB1 inhibits intrahepatic cholangiocarcinoma by repressing the transcriptional activity of the immune checkpoint PD-L1.
Life sciences
Liu Z,Li S,Zeng J,Zhou X,Li H,Liu X,Li F,Jiang B,Zhao M,Ma T
Tue Sep 15 00:00:00 UTC 2020
Hepatic Artery Embolization Enhances Expression of Programmed Cell Death 1 Ligand 1 in an Orthotopic Rat Hepatocellular Carcinoma Model: In Vivo and in Vitro Experimentation.
Journal of vascular and interventional radiology : JVIR
Takaki H,Hirata Y,Ueshima E,Kodama H,Matsumoto S,Wada R,Suzuki H,Nakasho K,Yamakado K
Tue Sep 01 00:00:00 UTC 2020
Prognostic perspectives of PD-L1 combined with tumor-infiltrating lymphocytes, Epstein-Barr virus, and microsatellite instability in gastric carcinomas.
Diagnostic pathology
Choi E,Chang MS,Byeon SJ,Jin H,Jung KC,Kim H,Lee KL,Kim W,Park JH,Kim KH,Kim JS,Choi IS,Han DS,Ahn HS,Heo SC
Thu Jun 04 00:00:00 UTC 2020
Alpha-Fetoprotein Regulates the Expression of Immune-Related Proteins through the NF-κB (P65) Pathway in Hepatocellular Carcinoma Cells.
Journal of oncology
Li QT,Qiu MJ,Yang SL,Fang X,He XX,Wang MM,Li YN,Xiong ZF,Huang S
Sat Apr 16 00:00:00 UTC 2022
Ethyl Acetate Fraction from Hedyotis diffusa plus Scutellaria barbata Exerts Anti-Breast Cancer Effect via miR-200c-PDE7B/PD-L1-AKT/MAPK Axis.
Evidence-based complementary and alternative medicine : eCAM
Yang Y,Fang T,Cao YL,Lv YX,Chang QQ,Zhang DD
Sat Apr 16 00:00:00 UTC 2022
Epoxyazadiradione exhibit activities in head and neck squamous cell carcinoma by targeting multiple pathways.
Apoptosis : an international journal on programmed cell death
Rai V,Aggarwal SK,Verma SS,Awasthee N,Dhasmana A,Aggarwal S,Das SN,Nair MS,Yadav S,Gupta SC
Thu Oct 01 00:00:00 UTC 2020
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer.
Journal of experimental & clinical cancer research : CR
Camorani S,Passariello M,Agnello L,Esposito S,Collina F,Cantile M,Di Bonito M,Ulasov IV,Fedele M,Zannetti A,De Lorenzo C,Cerchia L
Mon Sep 07 00:00:00 UTC 2020
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer.
Journal of experimental & clinical cancer research : CR
Camorani S,Passariello M,Agnello L,Esposito S,Collina F,Cantile M,Di Bonito M,Ulasov IV,Fedele M,Zannetti A,De Lorenzo C,Cerchia L
Mon Sep 07 00:00:00 UTC 2020
BGC823 Cell Line with the Stable Expression of iRFP720 Retains Its Primary Properties with Promising Fluorescence Imaging Ability.
DNA and cell biology
Hu H,Zhang Z,Wang R,Wang Y,Jin J,Cai L,Yang J,Duan H,Wu Z,Fang Z,Liu B
Fri May 01 00:00:00 UTC 2020
IL-20 antagonist suppresses PD-L1 expression and prolongs survival in pancreatic cancer models.
Nature communications
Lu SW,Pan HC,Hsu YH,Chang KC,Wu LW,Chen WY,Chang MS
Mon Sep 14 00:00:00 UTC 2020
IL-20 antagonist suppresses PD-L1 expression and prolongs survival in pancreatic cancer models.
Nature communications
Lu SW,Pan HC,Hsu YH,Chang KC,Wu LW,Chen WY,Chang MS
Mon Sep 14 00:00:00 UTC 2020
Anti-inflammatory effects of α-MSH through p-CREB expression in sarcoidosis like granuloma model.
Scientific reports
Zhang C,Chery S,Lazerson A,Altman NH,Jackson R,Holt G,Campos M,Schally AV,Mirsaeidi M
Wed Apr 29 00:00:00 UTC 2020
Prognostic and Clinicopathological Value of Programmed Cell Death Ligand1 Expression in Patients With Small Cell Lung Cancer: A Meta-Analysis.
Frontiers in oncology
Cai H,Zhang H,Jiang Y
Mon Sep 28 00:00:00 UTC 2020
Epstein-Barr virus-encoded miR-BART5-5p upregulates PD-L1 through PIAS3/pSTAT3 modulation, worsening clinical outcomes of PD-L1-positive gastric carcinomas.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Yoon CJ,Chang MS,Kim DH,Kim W,Koo BK,Yun SC,Kim SH,Kim YS,Woo JH
Tue Sep 01 00:00:00 UTC 2020
Lactobacillus Attenuate the Progression of Pancreatic Cancer Promoted by Porphyromonas Gingivalis in Transgenic Mice.
Cancers
Chen SM,Hsu LJ,Lee HL,Lin CP,Huang SW,Lai CJ,Lin CW,Chen WT,Chen YJ,Lin YC,Yang CC,Jan MS
Thu Nov 26 00:00:00 UTC 2020
CDC27 Promotes Tumor Progression and Affects PD-L1 Expression in T-Cell Lymphoblastic Lymphoma.
Frontiers in oncology
Song Y,Song W,Li Z,Song W,Wen Y,Li J,Xia Q,Zhang M
Mon Feb 15 00:00:00 UTC 2021
PD-L1 gene promoter methylation represents a potential diagnostic marker in advanced gastric cancer.
Oncology letters
Lv D,Xing C,Cao L,Zhuo Y,Wu T,Gao N
Sat Feb 01 00:00:00 UTC 2020
PD-L1 and miR-34a are Prognostic Factors for Primary Gastric Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP.
Cancer management and research
Wang J,Shang S,Li J,Deng H,Ouyang L,Xie H,Zhu H,Li Y,Zuo C
Fri Apr 15 00:00:00 UTC 2022
MicroRNA‑487b‑3p inhibits osteosarcoma chemoresistance and metastasis by targeting ALDH1A3.
Oncology reports
Cheng M,Duan PG,Gao ZZ,Dai M
Tue Dec 01 00:00:00 UTC 2020
Adipose Tissue From Type 1 Diabetes Mellitus Patients Can Be Used to Generate Insulin-Producing Cells.
Pancreas
Ikemoto T,Tokuda K,Wada Y,Gao L,Miyazaki K,Yamada S,Saito Y,Imura S,Morine Y,Shimada M
Thu Oct 01 00:00:00 UTC 2020
Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression.
Molecular cell
Jin X,Ding D,Yan Y,Li H,Wang B,Ma L,Ye Z,Ma T,Wu Q,Rodrigues DN,Kohli M,Jimenez R,Wang L,Goodrich DW,de Bono J,Dong H,Wu H,Zhu R,Huang H
Thu Jan 03 00:00:00 UTC 2019
Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression.
Molecular cell
Jin X,Ding D,Yan Y,Li H,Wang B,Ma L,Ye Z,Ma T,Wu Q,Rodrigues DN,Kohli M,Jimenez R,Wang L,Goodrich DW,de Bono J,Dong H,Wu H,Zhu R,Huang H
Thu Jan 03 00:00:00 UTC 2019
Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression.
Molecular cell
Jin X,Ding D,Yan Y,Li H,Wang B,Ma L,Ye Z,Ma T,Wu Q,Rodrigues DN,Kohli M,Jimenez R,Wang L,Goodrich DW,de Bono J,Dong H,Wu H,Zhu R,Huang H
Thu Jan 03 00:00:00 UTC 2019
Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression.
Molecular cell
Jin X,Ding D,Yan Y,Li H,Wang B,Ma L,Ye Z,Ma T,Wu Q,Rodrigues DN,Kohli M,Jimenez R,Wang L,Goodrich DW,de Bono J,Dong H,Wu H,Zhu R,Huang H
Thu Jan 03 00:00:00 UTC 2019
Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression.
Molecular cell
Jin X,Ding D,Yan Y,Li H,Wang B,Ma L,Ye Z,Ma T,Wu Q,Rodrigues DN,Kohli M,Jimenez R,Wang L,Goodrich DW,de Bono J,Dong H,Wu H,Zhu R,Huang H
Thu Jan 03 00:00:00 UTC 2019
TFEB Mediates Immune Evasion and Resistance to mTOR Inhibition of Renal Cell Carcinoma via Induction of PD-L1.
Clinical cancer research : an official journal of the American Association for Cancer Research
Zhang C,Duan Y,Xia M,Dong Y,Chen Y,Zheng L,Chai S,Zhang Q,Wei Z,Liu N,Wang J,Sun C,Tang Z,Cheng X,Wu J,Wang G,Zheng F,Laurence A,Li B,Yang XP
Fri Nov 15 00:00:00 UTC 2019
Aberrant PD-1 ligand expression contributes to the myocardial inflammatory injury caused by Coxsackievirus B infection.
Antiviral research
Wang T,Chen S,Wang X,Huang Y,Qiu J,Fei Y,Chaulagain A,Chen Y,Wang Y,Lin L,Yan B,Wang Y,Wang W,Zhao W,Zhong Z
Sat Jun 01 00:00:00 UTC 2019
Vaccine against gastrin, a polyclonal antibody stimulator, decreases pancreatic cancer metastases.
American journal of physiology. Gastrointestinal and liver physiology
Osborne N,Sundseth R,Gay MD,Cao H,Tucker RD,Nadella S,Wang S,Liu X,Kroemer A,Sutton L,Cato A,Smith JP
Fri Nov 01 00:00:00 UTC 2019
Targeting the YB-1/PD-L1 Axis to Enhance Chemotherapy and Antitumor Immunity.
Cancer immunology research
Tao Z,Ruan H,Sun L,Kuang D,Song Y,Wang Q,Wang T,Hao Y,Chen K
Mon Jul 01 00:00:00 UTC 2019
Targeting the YB-1/PD-L1 Axis to Enhance Chemotherapy and Antitumor Immunity.
Cancer immunology research
Tao Z,Ruan H,Sun L,Kuang D,Song Y,Wang Q,Wang T,Hao Y,Chen K
Mon Jul 01 00:00:00 UTC 2019
Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1.
Journal of experimental & clinical cancer research : CR
D'Alterio C,Buoncervello M,Ieranò C,Napolitano M,Portella L,Rea G,Barbieri A,Luciano A,Scognamiglio G,Tatangelo F,Anniciello AM,Monaco M,Cavalcanti E,Maiolino P,Romagnoli G,Arra C,Botti G,Gabriele L,Scala S
Mon Oct 28 00:00:00 UTC 2019
The Novel Combination of Nitroxoline and PD-1 Blockade, Exerts a Potent Antitumor Effect in a Mouse Model of Prostate Cancer.
International journal of biological sciences
Xu N,Huang L,Li X,Watanabe M,Li C,Xu A,Liu C,Li Q,Araki M,Wada K,Nasu Y,Huang P
Mon Mar 16 00:00:00 UTC 2020
Expression of PD-1/PD-L1 in head and neck squamous cell carcinoma and its clinical significance.
The International journal of biological markers
Chen SW,Li SH,Shi DB,Jiang WM,Song M,Yang AK,Li YD,Bei JX,Chen WK,Zhang Q
Sun Dec 01 00:00:00 UTC 2019
Mycobacterium abscessus-Bronchial Epithelial Cells Cross-Talk Through Type I Interferon Signaling.
Frontiers in immunology
Zhang C,Asif H,Holt GE,Griswold AJ,Campos M,Bejarano P,Fregien NL,Mirsaeidi M
Mon Nov 09 00:00:00 UTC 2020
Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours.
Nature biomedical engineering
Yao H,Lan J,Li C,Shi H,Brosseau JP,Wang H,Lu H,Fang C,Zhang Y,Liang L,Zhou X,Wang C,Xue Y,Cui Y,Xu J
Mon Apr 01 00:00:00 UTC 2019
Bifidobacterium infantis Induces Protective Colonic PD-L1 and Foxp3 Regulatory T Cells in an Acute Murine Experimental Model of Inflammatory Bowel Disease.
Gut and liver
Zhou L,Liu D,Xie Y,Yao X,Li Y
Fri Mar 15 00:00:00 UTC 2019
Doxorubicin and siRNA-PD-L1 co-delivery with T7 modified ROS-sensitive nanoparticles for tumor chemoimmunotherapy.
International journal of pharmaceutics
Wan WJ,Qu CX,Zhou YJ,Zhang L,Chen MT,Liu Y,You BG,Li F,Wang DD,Zhang XN
Sat Jul 20 00:00:00 UTC 2019
A Novel 3D in Vitro Tumor Model Based on Silk Fibroin/Chitosan Scaffolds To Mimic the Tumor Microenvironment.
ACS applied materials & interfaces
Li J,Zhou Y,Chen W,Yuan Z,You B,Liu Y,Yang S,Li F,Qu C,Zhang X
Wed Oct 31 00:00:00 UTC 2018
A Novel 3D in Vitro Tumor Model Based on Silk Fibroin/Chitosan Scaffolds To Mimic the Tumor Microenvironment.
ACS applied materials & interfaces
Li J,Zhou Y,Chen W,Yuan Z,You B,Liu Y,Yang S,Li F,Qu C,Zhang X
Wed Oct 31 00:00:00 UTC 2018
Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4-miR-18a pathway in cervical cancer.
Oncogene
Dong P,Xiong Y,Yu J,Chen L,Tao T,Yi S,Hanley SJB,Yue J,Watari H,Sakuragi N
Sat Sep 01 00:00:00 UTC 2018
Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4-miR-18a pathway in cervical cancer.
Oncogene
Dong P,Xiong Y,Yu J,Chen L,Tao T,Yi S,Hanley SJB,Yue J,Watari H,Sakuragi N
Sat Sep 01 00:00:00 UTC 2018
Effects of three-dimensional collagen scaffolds on the expression profiles and biological functions of glioma cells.
International journal of oncology
Jia W,Jiang X,Liu W,Wang L,Zhu B,Zhu H,Liu X,Zhong M,Xie D,Huang W,Jia W,Li S,Liu X,Zuo X,Cheng D,Dai J,Ren C
Fri Jun 01 00:00:00 UTC 2018
Effects of three-dimensional collagen scaffolds on the expression profiles and biological functions of glioma cells.
International journal of oncology
Jia W,Jiang X,Liu W,Wang L,Zhu B,Zhu H,Liu X,Zhong M,Xie D,Huang W,Jia W,Li S,Liu X,Zuo X,Cheng D,Dai J,Ren C
Fri Jun 01 00:00:00 UTC 2018
PD-1/PD-L1 Axis, Rather Than High-Mobility Group Alarmins or CD8+ Tumor-Infiltrating Lymphocytes, Is Associated With Survival in Head and Neck Squamous Cell Carcinoma Patients Who Received Surgical Resection.
Frontiers in oncology
Yang F,Zeng Z,Li J,Zheng Y,Wei F,Ren X
Thu Oct 01 00:00:00 UTC 2020
PD-1/PD-L1 Axis, Rather Than High-Mobility Group Alarmins or CD8+ Tumor-Infiltrating Lymphocytes, Is Associated With Survival in Head and Neck Squamous Cell Carcinoma Patients Who Received Surgical Resection.
Frontiers in oncology
Yang F,Zeng Z,Li J,Zheng Y,Wei F,Ren X
Thu Oct 01 00:00:00 UTC 2020
The Significance of the PD-L1 Expression in Non-Small-Cell Lung Cancer: Trenchant Double Swords as Predictive and Prognostic Markers.
Clinical lung cancer
Takada K,Toyokawa G,Shoji F,Okamoto T,Maehara Y
Thu Mar 01 00:00:00 UTC 2018
The Significance of the PD-L1 Expression in Non-Small-Cell Lung Cancer: Trenchant Double Swords as Predictive and Prognostic Markers.
Clinical lung cancer
Takada K,Toyokawa G,Shoji F,Okamoto T,Maehara Y
Thu Mar 01 00:00:00 UTC 2018
MicroRNA-140 suppresses osteosarcoma tumor growth by enhancing anti-tumor immune response and blocking mTOR signaling.
Biochemical and biophysical research communications
Ji X,Wang E,Tian F
Mon Jan 01 00:00:00 UTC 2018
MicroRNA-140 suppresses osteosarcoma tumor growth by enhancing anti-tumor immune response and blocking mTOR signaling.
Biochemical and biophysical research communications
Ji X,Wang E,Tian F
Mon Jan 01 00:00:00 UTC 2018
MicroRNA-140 suppresses osteosarcoma tumor growth by enhancing anti-tumor immune response and blocking mTOR signaling.
Biochemical and biophysical research communications
Ji X,Wang E,Tian F
Mon Jan 01 00:00:00 UTC 2018
Bone marrow mesenchymal stromal cells attenuate liver allograft rejection may via upregulation PD-L1 expression through downregulation of miR-17-5p.
Transplant immunology
Chen Q,Zhou R,Zhang Y,Zhu S,Xiao C,Gong J,Li K,Tang H,Sun C,Zhang J
Sat Dec 01 00:00:00 UTC 2018
Bone marrow mesenchymal stromal cells attenuate liver allograft rejection may via upregulation PD-L1 expression through downregulation of miR-17-5p.
Transplant immunology
Chen Q,Zhou R,Zhang Y,Zhu S,Xiao C,Gong J,Li K,Tang H,Sun C,Zhang J
Sat Dec 01 00:00:00 UTC 2018
[Small interfering RNA-mediated programmed cell death-ligand 1 silencing in human glioma cells enhances human CD8+ T lymphocyte cytotoxicity in vitro].
Nan fang yi ke da xue xue bao = Journal of Southern Medical University
Wang Z,Huang W,Cen B,Wei Y,Liao L,Li G,Ji A
Mon Jul 30 00:00:00 UTC 2018
Combined VEGF and PD-L1 Blockade Displays Synergistic Treatment Effects in an Autochthonous Mouse Model of Small Cell Lung Cancer.
Cancer research
Meder L,Schuldt P,Thelen M,Schmitt A,Dietlein F,Klein S,Borchmann S,Wennhold K,Vlasic I,Oberbeck S,Riedel R,Florin A,Golfmann K,Schlößer HA,Odenthal M,Buettner R,Wolf J,Hallek M,Herling M,von Bergwelt-Baildon M,Reinhardt HC,Ullrich RT
Wed Aug 01 00:00:00 UTC 2018
Expression of TLR4 in Non-Small Cell Lung Cancer Is Associated with PD-L1 and Poor Prognosis in Patients Receiving Pulmonectomy.
Frontiers in immunology
Wang K,Wang J,Wei F,Zhao N,Yang F,Ren X
Wed Mar 16 00:00:00 UTC 2022
Expression of TLR4 in Non-Small Cell Lung Cancer Is Associated with PD-L1 and Poor Prognosis in Patients Receiving Pulmonectomy.
Frontiers in immunology
Wang K,Wang J,Wei F,Zhao N,Yang F,Ren X
Wed Mar 16 00:00:00 UTC 2022
Altered status of programmed death-ligand 1 after recurrence in resected lung adenocarcinoma patients.
OncoTargets and therapy
Chen J,Li H,Pang R,Huang J
Wed Mar 16 00:00:00 UTC 2022
Altered status of programmed death-ligand 1 after recurrence in resected lung adenocarcinoma patients.
OncoTargets and therapy
Chen J,Li H,Pang R,Huang J
Wed Mar 16 00:00:00 UTC 2022
Globo H expression is associated with driver mutations and PD-L1 expressions in stage I non-small cell lung cancer.
Cancer biomarkers : section A of Disease markers
Yang CY,Lin MW,Chang YL,Wu CT
Tue Dec 12 00:00:00 UTC 2017
Globo H expression is associated with driver mutations and PD-L1 expressions in stage I non-small cell lung cancer.
Cancer biomarkers : section A of Disease markers
Yang CY,Lin MW,Chang YL,Wu CT
Tue Dec 12 00:00:00 UTC 2017
miR-142-5p regulates tumor cell PD-L1 expression and enhances anti-tumor immunity.
Biochemical and biophysical research communications
Jia L,Xi Q,Wang H,Zhang Z,Liu H,Cheng Y,Guo X,Zhang J,Zhang Q,Zhang L,Xue Z,Li Y,Da Y,Zhao P,Zhang R
Sat Jun 24 00:00:00 UTC 2017
miR-142-5p regulates tumor cell PD-L1 expression and enhances anti-tumor immunity.
Biochemical and biophysical research communications
Jia L,Xi Q,Wang H,Zhang Z,Liu H,Cheng Y,Guo X,Zhang J,Zhang Q,Zhang L,Xue Z,Li Y,Da Y,Zhao P,Zhang R
Sat Jun 24 00:00:00 UTC 2017
PD-1 Blockade Prevents the Development and Progression of Carcinogen-Induced Oral Premalignant Lesions.
Cancer prevention research (Philadelphia, Pa.)
Wang J,Xie T,Wang B,William WN,Heymach JV,El-Naggar AK,Myers JN,Caulin C
Fri Dec 01 00:00:00 UTC 2017
PD-1 Blockade Prevents the Development and Progression of Carcinogen-Induced Oral Premalignant Lesions.
Cancer prevention research (Philadelphia, Pa.)
Wang J,Xie T,Wang B,William WN,Heymach JV,El-Naggar AK,Myers JN,Caulin C
Fri Dec 01 00:00:00 UTC 2017
PD-1 Blockade Prevents the Development and Progression of Carcinogen-Induced Oral Premalignant Lesions.
Cancer prevention research (Philadelphia, Pa.)
Wang J,Xie T,Wang B,William WN,Heymach JV,El-Naggar AK,Myers JN,Caulin C
Fri Dec 01 00:00:00 UTC 2017
Crk adaptor protein promotes PD-L1 expression, EMT and immune evasion in a murine model of triple-negative breast cancer.
Oncoimmunology
Kumar S,Davra V,Obr AE,Geng K,Wood TL,De Lorenzo MS,Birge RB
Tue Jan 12 00:00:00 UTC 2021
Crk adaptor protein promotes PD-L1 expression, EMT and immune evasion in a murine model of triple-negative breast cancer.
Oncoimmunology
Kumar S,Davra V,Obr AE,Geng K,Wood TL,De Lorenzo MS,Birge RB
Tue Jan 12 00:00:00 UTC 2021
A Trp53fl/flPtenfl/fl mouse model of undifferentiated pleomorphic sarcoma mediated by adeno-Cre injection and in vivo bioluminescence imaging.
PloS one
Buchakjian MR,Merritt NM,Moose DL,Dupuy AJ,Tanas MR,Henry MD
Thu Oct 19 00:00:00 UTC 2017
A Trp53fl/flPtenfl/fl mouse model of undifferentiated pleomorphic sarcoma mediated by adeno-Cre injection and in vivo bioluminescence imaging.
PloS one
Buchakjian MR,Merritt NM,Moose DL,Dupuy AJ,Tanas MR,Henry MD
Thu Oct 19 00:00:00 UTC 2017
PD-1/PD-L1 interaction up-regulates MDR1/P-gp expression in breast cancer cells via PI3K/AKT and MAPK/ERK pathways.
Oncotarget
Liu S,Chen S,Yuan W,Wang H,Chen K,Li D,Li D
Tue Nov 21 00:00:00 UTC 2017
PD-1/PD-L1 interaction up-regulates MDR1/P-gp expression in breast cancer cells via PI3K/AKT and MAPK/ERK pathways.
Oncotarget
Liu S,Chen S,Yuan W,Wang H,Chen K,Li D,Li D
Tue Nov 21 00:00:00 UTC 2017
miR-217 inhibits laryngeal cancer metastasis by repressing AEG-1 and PD-L1 expression.
Oncotarget
Miao S,Mao X,Zhao S,Song K,Xiang C,Lv Y,Jiang H,Wang L,Li B,Yang X,Yuan Z,Xiu C,Meng H,Sun J
Fri Sep 22 00:00:00 UTC 2017
miR-217 inhibits laryngeal cancer metastasis by repressing AEG-1 and PD-L1 expression.
Oncotarget
Miao S,Mao X,Zhao S,Song K,Xiang C,Lv Y,Jiang H,Wang L,Li B,Yang X,Yuan Z,Xiu C,Meng H,Sun J
Fri Sep 22 00:00:00 UTC 2017
Preclinical immunoPET/CT imaging using Zr-89-labeled anti-PD-L1 monoclonal antibody for assessing radiation-induced PD-L1 upregulation in head and neck cancer and melanoma.
Oncoimmunology
Kikuchi M,Clump DA,Srivastava RM,Sun L,Zeng D,Diaz-Perez JA,Anderson CJ,Edwards WB,Ferris RL
Tue Apr 05 00:00:00 UTC 2022
Preclinical immunoPET/CT imaging using Zr-89-labeled anti-PD-L1 monoclonal antibody for assessing radiation-induced PD-L1 upregulation in head and neck cancer and melanoma.
Oncoimmunology
Kikuchi M,Clump DA,Srivastava RM,Sun L,Zeng D,Diaz-Perez JA,Anderson CJ,Edwards WB,Ferris RL
Tue Apr 05 00:00:00 UTC 2022
Radiation improves antitumor effect of immune checkpoint inhibitor in murine hepatocellular carcinoma model.
Oncotarget
Kim KJ,Kim JH,Lee SJ,Lee EJ,Shin EC,Seong J
Tue Jun 20 00:00:00 UTC 2017
Radiation improves antitumor effect of immune checkpoint inhibitor in murine hepatocellular carcinoma model.
Oncotarget
Kim KJ,Kim JH,Lee SJ,Lee EJ,Shin EC,Seong J
Tue Jun 20 00:00:00 UTC 2017
High PD-L1 expression is associated with stage IV disease and poorer overall survival in 186 cases of small cell lung cancers.
Oncotarget
Chang YL,Yang CY,Huang YL,Wu CT,Yang PC
Tue Mar 14 00:00:00 UTC 2017
High PD-L1 expression is associated with stage IV disease and poorer overall survival in 186 cases of small cell lung cancers.
Oncotarget
Chang YL,Yang CY,Huang YL,Wu CT,Yang PC
Tue Mar 14 00:00:00 UTC 2017
Programmed cell death-ligand 1 expression is associated with a favourable immune microenvironment and better overall survival in stage I pulmonary squamous cell carcinoma.
European journal of cancer (Oxford, England : 1990)
Yang CY,Lin MW,Chang YL,Wu CT,Yang PC
Fri Apr 01 00:00:00 UTC 2016
Programmed cell death-ligand 1 expression is associated with a favourable immune microenvironment and better overall survival in stage I pulmonary squamous cell carcinoma.
European journal of cancer (Oxford, England : 1990)
Yang CY,Lin MW,Chang YL,Wu CT,Yang PC
Fri Apr 01 00:00:00 UTC 2016
High co-expression of PD-L1 and HIF-1α correlates with tumour necrosis in pulmonary pleomorphic carcinoma.
European journal of cancer (Oxford, England : 1990)
Chang YL,Yang CY,Lin MW,Wu CT,Yang PC
Wed Jun 01 00:00:00 UTC 2016
High co-expression of PD-L1 and HIF-1α correlates with tumour necrosis in pulmonary pleomorphic carcinoma.
European journal of cancer (Oxford, England : 1990)
Chang YL,Yang CY,Lin MW,Wu CT,Yang PC
Wed Jun 01 00:00:00 UTC 2016
Predicting PD-L1 expression on human cancer cells using next-generation sequencing information in computational simulation models.
Cancer immunology, immunotherapy : CII
Lanzel EA,Paula Gomez Hernandez M,Bates AM,Treinen CN,Starman EE,Fischer CL,Parashar D,Guthmiller JM,Johnson GK,Abbasi T,Vali S,Brogden KA
Thu Dec 01 00:00:00 UTC 2016
Predicting PD-L1 expression on human cancer cells using next-generation sequencing information in computational simulation models.
Cancer immunology, immunotherapy : CII
Lanzel EA,Paula Gomez Hernandez M,Bates AM,Treinen CN,Starman EE,Fischer CL,Parashar D,Guthmiller JM,Johnson GK,Abbasi T,Vali S,Brogden KA
Thu Dec 01 00:00:00 UTC 2016
WITHDRAWN: Prognostic Significance of Programmed Cell Death-Ligand 1 Expression in Patients With Resected Lung Adenocarcinoma.
The Annals of thoracic surgery
Hung JJ,Huang SF,Shen YY,Wu YC,Chou TY,Hsu WH
Thu Oct 13 00:00:00 UTC 2016
WITHDRAWN: Prognostic Significance of Programmed Cell Death-Ligand 1 Expression in Patients With Resected Lung Adenocarcinoma.
The Annals of thoracic surgery
Hung JJ,Huang SF,Shen YY,Wu YC,Chou TY,Hsu WH
Thu Oct 13 00:00:00 UTC 2016
The prevalence and clinicopathological features of programmed death-ligand 1 (PD-L1) expression: a pooled analysis of literatures.
Oncotarget
Lin Z,Xu Y,Zhang Y,He Q,Zhang J,He J,Liang W
Tue Mar 22 00:00:00 UTC 2016
Assessing the Effects of Concurrent versus Sequential Cisplatin/Radiotherapy on Immune Status in Lung Tumor-Bearing C57BL/6 Mice.
Cancer immunology research
Kao CJ,Wurz GT,Lin YC,Vang DP,Griffey SM,Wolf M,DeGregorio MW
Wed Jul 01 00:00:00 UTC 2015
Assessing the Effects of Concurrent versus Sequential Cisplatin/Radiotherapy on Immune Status in Lung Tumor-Bearing C57BL/6 Mice.
Cancer immunology research
Kao CJ,Wurz GT,Lin YC,Vang DP,Griffey SM,Wolf M,DeGregorio MW
Wed Jul 01 00:00:00 UTC 2015
Immunological markers predict the prognosis of patients with squamous non-small cell lung cancer.
Immunologic research
Jiang L,Zhao Z,Jiang S,Lin Y,Yang H,Xie Z,Lin Y,Long H
Wed Jul 01 00:00:00 UTC 2015
Immunological markers predict the prognosis of patients with squamous non-small cell lung cancer.
Immunologic research
Jiang L,Zhao Z,Jiang S,Lin Y,Yang H,Xie Z,Lin Y,Long H
Wed Jul 01 00:00:00 UTC 2015
Prognostic significance of programmed cell death 1 (PD-1) or PD-1 ligand 1 (PD-L1) Expression in epithelial-originated cancer: a meta-analysis.
Medicine
Zhang Y,Kang S,Shen J,He J,Jiang L,Wang W,Guo Z,Peng G,Chen G,He J,Liang W
Sun Feb 01 00:00:00 UTC 2015
Programmed cell death-ligand 1 expression in surgically resected stage I pulmonary adenocarcinoma and its correlation with driver mutations and clinical outcomes.
European journal of cancer (Oxford, England : 1990)
Yang CY,Lin MW,Chang YL,Wu CT,Yang PC
Thu May 01 00:00:00 UTC 2014
Programmed cell death-ligand 1 expression in surgically resected stage I pulmonary adenocarcinoma and its correlation with driver mutations and clinical outcomes.
European journal of cancer (Oxford, England : 1990)
Yang CY,Lin MW,Chang YL,Wu CT,Yang PC
Thu May 01 00:00:00 UTC 2014
Role of programmed death ligands in effective T-cell interactions in extranodal natural killer/T-cell lymphoma.
Oncology letters
Han L,Liu F,Li R,Li Z,Chen X,Zhou Z,Zhang X,Hu T,Zhang Y,Young K,Sun S,Wen J,Zhang M
Wed Oct 01 00:00:00 UTC 2014
Role of programmed death ligands in effective T-cell interactions in extranodal natural killer/T-cell lymphoma.
Oncology letters
Han L,Liu F,Li R,Li Z,Chen X,Zhou Z,Zhang X,Hu T,Zhang Y,Young K,Sun S,Wen J,Zhang M
Wed Oct 01 00:00:00 UTC 2014
